Cargando…
Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study
Proposing a theory about the pathophysiology of cytokine storm in COVID19, we were to find the potential drugs to treat this disease and to find any effect of these drugs on the virus infectivity through an in silico study. COVID-19-induced ARDS is linked to a cytokine storm phenomenon not explainab...
Autores principales: | Nejat, Reza, Sadr, Ahmad Shahir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716628/ https://www.ncbi.nlm.nih.gov/pubmed/33294307 http://dx.doi.org/10.1007/s40203-020-00058-7 |
Ejemplares similares
-
Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids
por: Rahmani, Waleed, et al.
Publicado: (2022) -
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
por: Choudhury, Abhigyan, et al.
Publicado: (2021) -
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
por: Morales-Ortega, Alejandro, et al.
Publicado: (2022) -
Imatinib is not a potent anti-SARS-CoV-2 drug
por: Zhao, Helong, et al.
Publicado: (2020) -
Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
por: Campione, Elena, et al.
Publicado: (2021)